NO982349L - Nye kinoksalindionderivater, deres fremstilling og anvendelse i legemidler - Google Patents

Nye kinoksalindionderivater, deres fremstilling og anvendelse i legemidler

Info

Publication number
NO982349L
NO982349L NO982349A NO982349A NO982349L NO 982349 L NO982349 L NO 982349L NO 982349 A NO982349 A NO 982349A NO 982349 A NO982349 A NO 982349A NO 982349 L NO982349 L NO 982349L
Authority
NO
Norway
Prior art keywords
pharmaceuticals
derivatives
preparation
new
kinoxalindione
Prior art date
Application number
NO982349A
Other languages
English (en)
Norwegian (no)
Other versions
NO982349D0 (no
Inventor
Andreas Huth
Martin Krueger
Eckhard Ottow
Dieter Seidelmann
Roland Neuhaus
Herbert Schneider
Lechoslaw Turski
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO982349D0 publication Critical patent/NO982349D0/no
Publication of NO982349L publication Critical patent/NO982349L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/650952Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • C07F9/650994Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO982349A 1995-11-24 1998-05-22 Nye kinoksalindionderivater, deres fremstilling og anvendelse i legemidler NO982349L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19545251A DE19545251A1 (de) 1995-11-24 1995-11-24 Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
PCT/DE1996/002227 WO1997019066A1 (de) 1995-11-24 1996-11-15 Neue chinoxalindionderivate, deren herstellung und verwendung in arzneimitteln

Publications (2)

Publication Number Publication Date
NO982349D0 NO982349D0 (no) 1998-05-22
NO982349L true NO982349L (no) 1998-07-01

Family

ID=7779176

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982349A NO982349L (no) 1995-11-24 1998-05-22 Nye kinoksalindionderivater, deres fremstilling og anvendelse i legemidler

Country Status (20)

Country Link
EP (1) EP0876357A1 (de)
JP (1) JP2000500471A (de)
KR (1) KR19990071596A (de)
CN (1) CN1202891A (de)
AU (1) AU720083B2 (de)
CA (1) CA2238023A1 (de)
CZ (1) CZ160498A3 (de)
DE (1) DE19545251A1 (de)
EE (1) EE9800163A (de)
HU (1) HUP9902041A3 (de)
IL (1) IL124534A0 (de)
IS (1) IS4740A (de)
MX (1) MX9804068A (de)
NO (1) NO982349L (de)
NZ (1) NZ330492A (de)
PL (1) PL326844A1 (de)
SK (1) SK68298A3 (de)
TR (1) TR199800904T2 (de)
WO (1) WO1997019066A1 (de)
ZA (1) ZA969832B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19737446A1 (de) * 1997-08-22 1999-02-25 Schering Ag Verfahren zur Herstellung von Phosphonsäurederivaten
EP2338492A1 (de) 2009-12-24 2011-06-29 Universidad del Pais Vasco Verfahren und Zusammensetzung zur Behandlung von Alzheimer
CN106619953A (zh) * 2016-10-31 2017-05-10 山东省海盟生化科技有限公司 一种用于皮肤病的外用中药组合物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
DK69790D0 (da) * 1990-03-16 1990-03-16 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling af anvendelse
PT101004B (pt) * 1991-10-26 1999-10-29 Schering Ag Derivados da quinoxalina, processo para a sua preparacao e composicoes farmaceuticas que os contem
IL109397A0 (en) * 1993-04-28 1994-07-31 Schering Ag Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DE4439492A1 (de) * 1994-10-25 1996-05-02 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE4439493A1 (de) * 1994-10-25 1996-05-02 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE19519979A1 (de) * 1995-05-24 1996-11-28 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln

Also Published As

Publication number Publication date
EE9800163A (et) 1998-12-15
TR199800904T2 (xx) 1998-08-21
HUP9902041A2 (hu) 2000-04-28
ZA969832B (en) 1997-06-17
IS4740A (is) 1998-05-13
JP2000500471A (ja) 2000-01-18
AU1867497A (en) 1997-06-11
SK68298A3 (en) 1998-12-02
MX9804068A (es) 1998-09-30
NO982349D0 (no) 1998-05-22
CZ160498A3 (cs) 1998-09-16
KR19990071596A (ko) 1999-09-27
AU720083B2 (en) 2000-05-25
WO1997019066A1 (de) 1997-05-29
NZ330492A (en) 1999-10-28
CA2238023A1 (en) 1997-05-29
PL326844A1 (en) 1998-10-26
CN1202891A (zh) 1998-12-23
EP0876357A1 (de) 1998-11-11
IL124534A0 (en) 1998-12-06
DE19545251A1 (de) 1997-05-28
HUP9902041A3 (en) 2000-07-28

Similar Documents

Publication Publication Date Title
DK0871606T3 (da) Nye forbindelser og deres præparat med anti-inflammatorisk og anti-thrombotisk aktivitet
NO991732L (no) Nye heterocyklylmetylsubstituerte pyrazolderivater
DE59711733D1 (de) 3-thiocarbamoylpyrazol-derivate als pestiziden
TR199700803T1 (xx) Trombin-inhibit�rleri olarak yeni dipeptidik amidinler.
ATE233274T1 (de) Oxyiminopregnancarbolactone
NO992821L (no) Ketobenzamider som calpain-inhibitorer
NO992400L (no) Nye substituerte pyrazolderivater
IS1846B (is) Setin N-(indól-2-karbónýl)-b-alaninamíð, notkun þeirra og lyfjaefnablöndur
ATE280160T1 (de) Substituierte aryl-oder heteroarylamide mit retinoid-ähnlicher biologischer aktivität
CA2107105A1 (en) Heterocyclic-cyclic amine derivatives
SE9504661D0 (sv) New compounds
NO975711D0 (no) Nye Dolastatinderivater, deres fremstilling og anvendelse
NO992770L (no) Nye heterocyklisk substituerte benzamider og deres anvendelse ved bekjempelse av sykdommer
DE69021501D1 (de) Anti-entzündende 4-aminophenol-derivate.
DE60139382D1 (de) 2-hydroxy-mutilin-carbamat derivate und ihre anwendung als antibakterielle mittel
NO971625L (no) Nye peptider med immunomodulatoriske effekter
DK0810991T3 (da) 1-Aryl-2-acylamino-ethan-forbindelser og deres anvendelse som neurokinin- især neurokinin-1-antagonister
DE69530988D1 (de) Benzimidazolderivate mit dopaminerger wirkung
NO306400B1 (no) N-substituerte azabicykloheptan-derivater, anvendelse derav og farmasöytisk preparat
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
NO954328L (no) Nye substituerte 1-fenyl-pyridinyl-benzotriazoler
NO982349L (no) Nye kinoksalindionderivater, deres fremstilling og anvendelse i legemidler
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
NO921906L (no) Nye 2-amino-5-cyano-1,4-dihydropyridiner, deres fremstilling og anvendelse i legemidler
NO970435L (no) Nye, 3-substituerte 3H-2,3-benzodiazepinderivater, fremstilling av dem og anvendelse av dem som legemidler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application